Suchergebnisse - "Tarantino, Paolo"

PubPharm (120)

11

Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan

enthalten in: Current oncology reports | 2023

von Neupane, N. | Thapa, S. | Bhattarai, A. | +5

12

Sequencing Antibody Drug Conjugates in Breast Cancer : Exploring Future Roles

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Fenton, M. | Tarantino, P. | Graff, S.

13

Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

enthalten in: Nature communications | 2023

von Tarantino, P. | Gupta, H. | Hughes, M. | +24

ErratumIn: Nat Commun. 2023 Dec 14;14(1):8321. - PMID 38097580

14

Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan

enthalten in: Current oncology reports | 2023

von Neupane, N. | Thapa, S. | Bhattarai, A. | +5

15

Next-generation antibody-drug conjugates for breast cancer : Moving beyond HER2 and TROP2

enthalten in: Critical reviews in oncology/hematology | 2023

von Schlam, I. | Moges, R. | Morganti, S. | +2

16

The efficacy of trastuzumab-deruxtecan for the treatment of patients with advanced HER2-low breast cancer

enthalten in: Expert review of anticancer therapy | 2023

von Schlam, I. | Tolaney, S. | Tarantino, P.

17

The American Society of Clinical Oncology-College of American Pathologists Guideline Update for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

enthalten in: Archives of pathology & laboratory medicine | 2023

von Schnitt, S. | Tarantino, P. | Collins, L.

18

Detecting and Managing T-DXd-Related Interstitial Lung Disease : The Five "S" Rules

enthalten in: JCO oncology practice | 2023

von Tarantino, P. | Tolaney, S.

CommentOn: JCO Oncol Pract. 2023 Aug;19(8):539-546. - PMID 37207306

19

Optimizing the safety of antibody-drug conjugates for patients with solid tumours

enthalten in: Nature reviews. Clinical oncology | 2023

von Tarantino, P. | Ricciuti, B. | Pradhan, S. | +1

20

Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer : Implications for Guidance and Reimbursement

enthalten in: JCO oncology practice | 2023

von Trapani, D. | Jin, Q. | Block, C. | +11